DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
Rosenberg JE, Heath EI, O'Donnell PH. et al.
EV-201 Study: A single-arm, open-label, multicenter study of enfortumab vedotin for treatment of patients with locally advanced or metastatic urothelial cancer who previously received immune checkpoint inhibitor therapy.
J Clin Oncol 2018;
36
DOI: 10.1200/JCO.2018.36.15_suppl.TPS4590.
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.